drugset / Trial / NCT01313247

Paracetamol for Cancer Pain

NCT01313247 ↗

Phase 4 Unknown 50 enrolled Haraldsplass Deaconess Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

Randomised, double-blind placebo controlled cross-over trial Main goal: Optimize the medical pain treatment for patients with advanced cancer disease Study goal: Measure paracetamol's additional analgesic effect in a situation where the patient is concomitantly treated with oral opioids eqv. morphine \> 100 mg/d.

Timeline

Start
2011-04
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg Oral